membrane insertion of Bax and Bcl-2-type molecules is required for their function. Mutants of Bcl-2 that do not insert into membranes have reduced capacity to regulate apoptosis (Hockenbery et al., 1993; Nguyen et al., 1993; Tanaka et al., 1993) . Similar mutants of Bax are also inactive, indicating that subcellular localization is important for their effects on apoptosis (Wolter et al., 1997) . However, which intracellular membrane these proteins must insert into is still unknown. Here, we discuss studies describing the subcellular localization of Bcl-2, its effect on apoptosis regulation on various membranes, and the distribution of pro-apoptotic Bcl-2 family members. We propose a specific role for Bcl-2 on the ER in regulating ER-to-mitochondrion communication involving BH3-only proteins and calcium signaling.
Bcl-2 and Bcl-xL subcellular localization
Bcl-2 localizes to the ER, the outer mitochondrial membrane and the nuclear membrane, as shown by subcellular fractionation (Janiak et al., 1994; Krajewski et al., 1993) and electron microscopy (Akao et al., 1994; Krajewski et al., 1993; Monaghan et al., 1992) . By contrast, the Bcl-2 family member Bcl-xL accumulates on the outer mitochondrial membrane (Kaufmann et al., 2003) . Bcl-2 and Bcl-xL insert into membranes through a hydrophobic C-terminal transmembrane (TM) domain, the bulk of the protein lying on the cytoplasmic side of the membrane.
Recent work by Kaufmann et al. showed that targeting of Bcl-2 and Bcl-xL to intracellular membranes depends on the number and position of basic residues in the TM domain (Kaufmann et al., 2003) . Bcl-xL has additional positively charged residues at the C-terminal end of the TM domain that are critical for specific mitochondrial targeting. This is in contrast to Bcl-2, and thus accounts for its ability to distribute between the ER, outer mitochondrial and nuclear membranes (Kaufmann et al., 2003) .
Interestingly, full-length Bcl-2 induces apoptosis when transiently expressed in cells, whereas Bcl-xL does not (Uhlmann et al., 1998; Wang et al., 2001) . The toxicity of transiently expressed Bcl-2 correlates with its expression on mitochondria, and is reproduced with a mutant form of Bcl-2 that is selectively targeted to mitochondria . Thus, mitochondria might not be the preferred site for prosurvival activities of Bcl-2.
ER-targeted Bcl-2
A great deal of information about the role of subcellular localization in Bcl-2 function has come from targeting mutants. The first such mutant is an ER-targeted form of Bcl-2 called Bcl-Cb5, in which the 21 C-terminal residues of Bcl-2 are replaced with the C-terminus of rat cytochrome B5 (Zhu et al., 1996) . Cytochrome B5 is a TM protein that localizes to the ER (Mitoma and Ito, 1992) . The Bcl-Cb5 fusion specifically targets the ER (Hacki et al., 2000; Zhu et al., 1996) and protects cells from apoptosis in some instances, but not in others (Zhu et al., 1996) . In particular, Bcl-Cb5 protects cells against apoptosis induced by Myc overexpression in Rat-1 fibroblasts, but does not inhibit serum-deprivation-induced apoptosis in Madin-Darby canine kidney (MDCK) cells. This is in contrast to a mitochondrion-targeted mutant and wild-type Bcl-2, which can inhibit serum-deprivation-induced apoptosis. The 'spatially distinct pathways' elucidated by this study were later expanded to include other factors. Lee et al. showed that the topoisomerase inhibitor etoposide induces apoptosis in cells overexpressing Bcl-Cb5, whereas Myc overexpression cannot (Lee et al., 1999) . In addition, these cells were shown to be resistant to apoptosis induced by staurosporine, brefeldin A/cycloheximide, tunicamycin (Hacki et al., 2000) , thapsigargin ) and ceramide (Annis et al., 2001) . Furthermore, Bcl-Cb5 inhibits apoptosis induced by Bax overexpression . Table 1 provides a summary of the various apoptotic inducers used to challenge the protective effect of Bcl-Cb5. In most cases, Bcl-Cb5 protects against apoptosis.
One conclusion that is clear from the studies of Bcl-Cb5 is that this mutant still protects the mitochondria. There are data suggesting that it can inhibit disruption of mitochondrial membrane potential (Annis et al., 2001) , release of cytochrome c from mitochondria (Hacki et al., 2000) and oligomerization of Bax (Thomenius et al., 2003) . Because all of these events occur on mitochondria, Bcl-Cb5 must have an indirect protective effect. In other words, there must be some factors that Bcl-2 affects that in turn affect mitochondria. On the basis of recent work from several laboratories, including our own, we propose that there are two primary pro-apoptotic factors regulated by Bcl-2 on the ER: BH3-only pro-apoptotic proteins and calcium ions. Evidence for both is summarized below.
Bcl-2 and pro-apoptotic Bcl-2 family members
The predominant hypothesis for the mechanism of Bcl-2 function is that it inhibits the action of pro-apoptotic Bcl-2 family members. In particular, Bcl-2 inhibits the activation of Bax, thereby protecting mitochondria and preventing cytochrome c release. It was initially thought that Bcl-2 inhibits Bax through a direct interaction . However, it is not clear that this interaction is necessary for the antiapoptotic activity of Bcl-2. Mutants of Bcl-xL that cannot bind to Bax can nevertheless protect against apoptosis (Cheng et al., 1996) . In addition, it has been demonstrated that Bax and BclCb5 do not interact during apoptosis, although Bcl-Cb5 does inhibit apoptosis (Annis et al., 2001) . Also, Bcl-Cb5 can inhibit the oligomerization of a mutant of Bax that is constitutively present on mitochondria (Thomenius et al., 2003) . Since Bcl- Cb5 and mitochondrial Bax are spatially separated, it is unlikely that they interact. Two models for how Bcl-2 inhibits apoptosis are prevalent in the literature (see Fig. 1 ). In the first, BH3-only proteins induce apoptosis by inhibiting the anti-apoptotic activity of Bcl-2 (Bouillet and Strasser, 2002) . However, there is emerging data suggesting BH3-only proteins have a toxic effect that is independent of Bcl-2 inhibition (Wei et al., 2001) . There is also evidence indicating that BH3-only proteins directly activate Bax (Desagher et al., 1999; Grinberg et al., 2002; Letai et al., 2002; Marani et al., 2002) or directly affect the mitochondria (Grinberg et al., 2002; Sugiyama et al., 2002) . These data suggest an alternative model in which Bcl-2 lies upstream of BH3-only proteins and inhibits them from activating Bax and inducing apoptosis. This model is also supported by recent findings suggesting that Bcl-Cb5 prevents the mitochondrial localization of a constitutively active form of the BH3-only protein Bad (Bad3A) (Thomenius et al., 2003) . Bad3A can bind to Bcl-2 on the ER, which suggests that Bcl-2 can inhibit BH3-only proteins at either the ER or the mitochondrial membrane. These findings could also explain the 'spatially distinct pathways' described by Zhu et al. (Zhu et al., 1996) : it might be necessary for Bcl-2 to be on mitochondria to bind to certain BH3-only proteins or to bind active Bax during responses to certain cell death stimuli. For instance, DNAdamaging agents such as etoposide and doxorubicin induce Bbc3/PUMA, which localizes to the mitochondria (Han et al., 2001) . Bcl-Cb5 might be unable to inhibit a mitochondrial BH3-only protein, because it cannot access it in the cell.
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The idea that Bcl-2 family members have a role on the ER is also strengthened by reports suggesting that pro-apoptotic Bcl-2 family members can also function on the ER. Two reports show that the BH3-only protein Bik can induce apoptosis from the ER (Germain et al., 2002; Mathai et al., 2002) . Bax and Bak can also stimulate apoptosis from the ER (Nutt et al., 2002; Scorrano et al., 2003; Zong et al., 2003) . Consistent with the proposed role of Bcl-2 on the ER are data supporting the notion that BH3 peptides can either sensitize cells to apoptosis by binding to anti-apoptotic proteins or induce apoptosis by activating multi-domain pro-apoptotic proteins (Letai et al., 2002) . Fig. 2 depicts a model whereby the 'sensitizer' BH3-only proteins (e.g. Bad) displace 'inducer' BH3-only proteins (e.g. Bid) sequestered to the ER by Bcl-2, thus initiating apoptosis.
There is also considerable work describing the interaction of Bcl-2 and the ER-resident protein Bap31 and the ability of this interaction to regulate the activation of caspases. Bap31 associates with procaspase 8, which results in cleavage of Bap31 and release of a pro-apoptotic fragment as well as active caspase 8. Bcl-2 inhibits this process by binding to Bap31 (Breckenridge et al., 2002; Ng and Shore, 1998; Nguyen et al., 2000) . This important area of Bcl-2 function has been reviewed extensively elsewhere (Rudner et al., 2002) and is therefore not discussed further here. Nevertheless, it is important to mention that recent work has revealed a novel ER-localized BH3-only protein called Spike, which regulates the interaction between Bcl-xL and Bap31 (Mund et al., 2003) . This lends further support to the role of Bcl-2 family members on the ER.
Bcl-2 and pro-apoptotic calcium signals
Another candidate for a factor that relays signals from ER-localized Bcl-2 to mitochondria is the calcium ion. Calcium has been implicated in the control of apoptosis through both the extrinsic (receptor-mediated) and intrinsic (mitochondriamediated) death pathways (reviewed by Orrenius et al., 2003) . Moreover, conditions that reduce the ER lumenal calcium concentration (i.e. low extracellular calcium or deficiency of the pro-apoptotic Bcl-2 family members Bax and Bak) protect mitochondria by impeding the transfer of calcium ions from the ER lumen to mitochondria (Pinton et al., 2001; Scorrano et al., 2003) . Calcium ions may communicate death signals from the ER to mitochondria either directly, by increasing mitochondrial calcium concentration, or indirectly, by triggering cell-intrinsic death pathways through calcineurin activation. In either case, calcium signals generated by inositol 1,4,5-trisphosphate (InsP3)-mediated release of calcium from the ER lumen are of central importance.
One of the primary functions of the ER is as a source of calcium signals that are released through InsP3 receptors (reviewed by Petersen, 2002; Putney et al., 2001; Berridge et al., 2003) . The modulation of intracellular calcium concentration is a common signaling mechanism used in many biological systems, including T and B lymphocytes, which rely on calcium signaling to initiate development, activation and death (reviewed by Lewis, 2001; Winslow et al., 2003) . Many agonists that induce increases in cytosolic calcium levels do so by stimulating the production of InsP3, which then binds to InsP3 receptors in the ER (reviewed by Patel et al., 1999; Thrower et al., 2001 ). These InsP3 receptors release calcium from the ER, generating spikes and waves whose frequencies and amplitudes transmit information that is sensed, for example, by calcium-sensitive phosphatases and kinases. InsP3-linked calcium signals activate intrinsic death pathways by direct and indirect effects on mitochondria (Fig.  3) . Mitochondria play crucial roles in both cell life and cell death. Increases in the level of mitochondrial matrix calcium evoked by calcium-mobilizing agonists play a fundamental role in cellular energy metabolism (reviewed by Smaili et al., 2000; Hajnoczky et al., 2000) . Mitochondria also play a central role in cell death by releasing apoptotic factors (e.g. cytochrome c) that activate caspases (reviewed by Desagher and Martinou, 2000; Ferri and Kroemer, 2001; Wang, 2001; Nieminen, 2003) . Apoptotic stimuli induce a switch in mitochondrial calcium signaling at the beginning of the apoptotic process by facilitating calcium-induced opening of the mitochondrial permeability transition pore (Szalai et al., 1999; Pacher and Hajnoczky, 2001 ). Thus, InsP3-linked calcium spikes can, under certain circumstances, trigger the mitochondrial permeability transition and, in turn, cytochrome c release. The apoptotic switch in mitochondrial calcium signaling can be mediated by the pro-apoptotic protein tcBid, which increases the magnitude of mitochondrial calcium signals by selectively permeabilizing the outer mitochondrial membrane (Csordas et al., 2002) . Calcium also activates cellintrinsic death pathways indirectly by activating calcineurin, which dephosphorylates and thereby activates the proapoptotic Bcl-2 family member Bad (Wang et al., 1999; Saito et al., 2000) or mediates induction of another Bcl-2 family member, Bik (Jiang and Clark, 2001) .
The full extent of involvement of InsP3-mediated calcium signals in apoptosis may not yet be realized. A deficiency of InsP3 receptors inhibits apoptosis induction by glucocorticosteroids and ionizing radiation in T cells (Jayaraman and Marks, 1997; Khan et al., 1996) and by surface IgM ligation in B cells (Sugawara et al., 1997) . Moreover, calcineurin overexpression sensitizes cells to apoptosis induction following growth factor withdrawal (Shibasaki and McKeon, 1995) . Thus, calcium signals appear to be involved in mediating apoptosis in response to a wide range of apoptotic stimuli.
A focal point of Bcl-2 action may be to impede calcium release from the ER and thereby inhibit activation of mitochondrial death pathways. Reports published almost a decade ago indicated that Bcl-2 inhibits calcium release from the ER, which dampens calcium oscillations and prevents redistribution of calcium from the ER to mitochondria following growth factor withdrawal (Baffy et al., 1993; Lam et al., 1994; Magnelli et al., 1994) . Subsequently, there have been conflicting theories about the mechanism. We have provided evidence that Bcl-2 inhibits calcium release from the ER and thereby preserves the ER calcium pool (Distelhorst et al., 1996; He et al., 1997) , whereas others have suggested that Bcl-2 suppresses ER calcium release by decreasing ER lumenal calcium concentration (Pinton et al., 2000; Foyouzi-Youssefi et al., 2000) . The latter reports indicating that Bcl-2 decreases ER lumenal calcium concentration relied heavily on transient expression of Bcl-2. This may be a problem because, as noted above, transient expression of wild-type Bcl-2 is toxic to a broad range of cell types, and actually induces apoptosis rather than inhibits it (Uhlmann et al., 1998; Wang et al., 2001) .
Bcl-2 on the ER can also interfere with calcium-mediated death signals through its interaction with the calcium-activated phosphatase calcineurin. Bcl-2 is known to form a tight complex with calcineurin, and calcineurin associated with Bcl-2 retains phosphatase activity (Shibasaki et al., 1997; Srivastava et al., 1999) . Recent findings confirm the association of Bcl-2 with calcineurin in brain cells and provide evidence that Bcl-2 docks calcineurin to InsP3 receptors (Erin et al., 2003a; Erin et al., 2003b) . Significantly, Linette et al. (Linette et al., 1996) demonstrated that Bcl-2 inhibits anti-CD3/T-cell receptor (TCR)-mediated activation of NFATc and induction of interleukin 2 (IL-2) expression, which thereby inhibits cellcycle entry by delaying G0/G1 transition into S phase and also inhibits TCR-activation-induced apoptosis. Active NFATc is generated by calcineurin, which binds to and dephosphorylates NFATc in the cytoplasm, permitting NFATc to enter the nucleus. It has been suggested that Bcl-2 inhibits NFATc activation by sequestering calcineurin to intracellular membranes (Shibasaki et al., 1997) .
In T cells, calcium/calcineurin-mediated activation of NFATc increases expression of IL-2, which in turn stimulates dual pathways, one leading to cell death and the other leading to cell survival. IL-2 induces cell death through Stat2-mediated induction of the death receptor ligand Fas, but promotes cell survival through Akt-mediated induction of Bcl-2 expression (Parijs et al., 1999) . This raises the possibility that increased expression of Bcl-2 may be part of a feedback loop that dampens InsP3-mediated calcium signals and thereby controls T-cell proliferation while maintaining cell survival. Indeed, we have found that Bcl-2 interacts with InsP3 receptors and inhibits InsP3-mediated calcium release from the ER (C.W.D., unpublished).
Conclusions
The Bcl-2 family has been studied extensively and yet no biochemical function has been proposed that definitively explains its effect on apoptosis. Studies of Bcl-Cb5 indicate that this effect can be performed on the ER. Thus, it is likely that there are functions of Bcl-2 that can operate on either mitochondrial or ER membranes.
The subcellular distribution of Bcl-2 proteins no doubt plays a crucial role in their ability to regulate apoptosis. The sequestration of BH3-only proteins by Bcl-2 on the ER appears to be an attractive protection mechanism because sequestration of these proteins solely to the mitochondria might be 'dangerous' for healthy cells. Keeping pro-apoptotic proteins at their sites of action might provide a rapid response, but it also might result in random and undesired apoptosis. It is more likely that Bcl-2 on the ER is a first line of defense against apoptotic signals and serves to keep pro-apoptotic proteins away from their site of action, whereas Bcl-2 and Bcl-xL on the mitochondria inhibit BH3-only proteins and multi-domain proteins that have already accumulated on the mitochondria. Evidence describing the role of ER-to-mitochondrion calcium signaling in apoptosis regulation is also growing, but how Bcl-2 family members regulate this process is unknown. Since Bcl-2 reduces InsP3 receptor activity by direct interaction (C.W.D., unpublished), and Bax and Bak increase calcium release from the ER (Nutt et al., 2002; Scorrano et al., 2003; Zong et al., 2003) , calcium is probably an important apoptotic signal from the ER.
